Arcutis Biotherapeutics, Inc. (ARQT)
29.45
-0.32
(-1.07%)
USD |
NASDAQ |
Dec 11, 16:00
29.44
-0.01
(-0.03%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash from Investing (Quarterly): -25.25M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics, Inc. | -14.37M |
| ANI Pharmaceuticals, Inc. | -6.163M |
| CorMedix, Inc. | -291.32M |
| Editas Medicine, Inc. | 39.57M |
| Syndax Pharmaceuticals, Inc. | 72.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.754M |
| Cash from Financing (Quarterly) | 1.476M |
| Free Cash Flow | -48.24M |
| Free Cash Flow Per Share (Quarterly) | -0.0132 |
| Free Cash Flow to Equity (Quarterly) | -5.365M |
| Free Cash Flow to Firm (Quarterly) | 1.284M |
| Free Cash Flow Yield | -1.28% |